Evolent
Runs risk-based and fee-based specialty-care programs covering oncology, cardiology, and musculoskeletal conditions for health plans.
$4.58
After-hours close−0.01 (−0.22%)
At close$4.59(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 101.75%Insiders 3.22%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 112.48M · Float 107.68M · 95.7% free float
Institutions13F, as of Jun 30, 2026
207 holders · 114.44M shares · 39 new positions · 107 increased · 65 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.81M | 13.17% | +3.93M | Aug 7, 2026 |
| Cadian Capital Management, LP | 10.81M | 9.61% | 0 | Aug 14, 2026 |
| Morgan Stanley | 8.97M | 7.97% | −112.1K | Aug 13, 2026 |
| UBS Group AG | 6.25M | 5.55% | −1.91M | Aug 13, 2026 |
| Rubicon Founders LLC | 5.82M | 5.17% | 0 | Aug 14, 2026 |
| Engaged Capital LLC | 5.56M | 4.95% | 0 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 5.11M | 4.54% | −326.5K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.79M | 4.26% | −79.4K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Cadian Capital Management, LP | 9.30% | 10.79M | 13G | May 15, 2025 ↗ |
| Morgan Stanley | 8.10% | 9.10M | 13G | Feb 11, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Seth Blackley | director, officer: Chief Executive Officer | 1.27M | 1.13% | Jul 6, 2026 |
| Daniel Joseph McCarthy | officer: PRESIDENT | 655.1K | 0.58% | Aug 28, 2026 |
| John Paul Johnson | officer: Chief Financial Officer | 309.2K | 0.27% | Jul 3, 2025 |
| Jonathan Weinberg | officer: General Counsel | 284.9K | 0.25% | Jul 6, 2026 |
| Emily Ann Rafferty | officer: Chief Operating Officer | 127.1K | 0.11% | Mar 4, 2025 |
| Kim Keck | director | 102.6K | 0.09% | Jun 8, 2026 |
| Brendan B. Springstubb | director | 99.9K | 0.09% | Jun 8, 2026 |
| Aammaad Shams | officer: Chief Accounting Officer | 95.6K | 0.09% | Jul 6, 2026 |
| Craig A. Barbarosh | director | 95.0K | 0.08% | Jun 8, 2026 |
| Richard M. Jelinek | director | 92.5K | 0.08% | Jun 8, 2026 |
5 ten-percent owners hold 11.06M shares by Form 4, outside the officers-and-directors figure above · 15 people have not refiled in the last 18 months (3.13M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Daniel Joseph McCarthyofficer: PRESIDENT | Sale | 65,892 | $5.00 | 655,133 |
| Nov 18, 2025 | Brendan B. Springstubbdirector | Purchase | 10,000 | $3.82 | 58,821 |
CongressHouse and Senate disclosures
Not reported.